AtaiBeckley (ATAI) Change in Cash (2020 - 2026)
AtaiBeckley's (ATAI) quarterly Change in Cash came in at -$42.2 million in Q1 2026, down 237.09% year-on-year from $30.8 million in Q1 2025, and down 237.09% quarter-over-quarter from $30.8 million in Q1 2025.
AtaiBeckley (ATAI) Change in Cash (2020 - 2026) Analysis & Trends
AtaiBeckley (ATAI) has 6 years of Change in Cash data on file, last reported at -$31.5 million in Q3 2025.
- For the quarter ending Q3 2025, Change in Cash fell 396.69% year-over-year to -$31.5 million; the trailing twelve-month figure through Sep 2025 stood at -$14.6 million (up 53.82% YoY), and the FY2024 full-year result was -$17.5 million, up 87.96% from the prior year.
- Change in Cash retreated to -$42.2 million in Q1 2026 per ATAI's latest filing, from $30.8 million in the prior quarter.
- Across five years, Change in Cash topped out at $30.8 million in Q1 2025 and bottomed at -$42.2 million in Q1 2026.
- A 5-year average of -$3.5 million and a median of -$11.2 million in 2024 frame the typical range for Change in Cash.
- Across the five-year window, Change in Cash tumbled 3445.37% in 2022 and jumped 685.59% in 2025, its largest moves.
- Tracing ATAI's Change in Cash over 5 years: stood at -$68.0 million in 2021, then soared by 170.65% to $48.1 million in 2022, then slumped by 165.44% to -$31.5 million in 2023, then surged by 44.5% to -$17.5 million in 2024, then slumped by 80.65% to -$31.5 million in 2025.
- Business Quant data shows ATAI's Change in Cash at -$31.5 million in Q3 2025, $3.7 million in Q2 2025, and $30.8 million in Q1 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -22.03 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 243.78 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -1.34 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 417.10 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -153.10 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 57.19 Mn |
| 10 | AtaiBeckley | 2.56 Bn | 2.56 Bn | - | -31.54 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -42.20 Mn |
| Sep 30, 2025 | -31.54 Mn |
| Jun 30, 2025 | 3.65 Mn |
| Mar 31, 2025 | 30.78 Mn |
| Mar 31, 2025 | 30.78 Mn |
| Dec 31, 2024 | -17.46 Mn |
| Sep 30, 2024 | 10.63 Mn |
| Jun 30, 2024 | 465,000.00 |
| Mar 31, 2024 | -11.17 Mn |
| Dec 31, 2023 | -31.46 Mn |
| Sep 30, 2023 | -64.60 Mn |
| Jun 30, 2023 | -44.80 Mn |
| Mar 31, 2023 | -4.73 Mn |
| Dec 31, 2022 | 48.07 Mn |
| Sep 30, 2022 | 58.41 Mn |
| Jun 30, 2022 | -39.84 Mn |
| Mar 31, 2022 | -238.29 Mn |
| Dec 31, 2021 | -68.04 Mn |
| Sep 30, 2021 | -23.31 Mn |
| Jun 30, 2021 | 349.25 Mn |